Diego Arango

7.4k total citations
83 papers, 5.2k citations indexed

About

Diego Arango is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Diego Arango has authored 83 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 38 papers in Oncology and 23 papers in Pathology and Forensic Medicine. Recurrent topics in Diego Arango's work include Genetic factors in colorectal cancer (23 papers), Colorectal Cancer Treatments and Studies (13 papers) and Epigenetics and DNA Methylation (10 papers). Diego Arango is often cited by papers focused on Genetic factors in colorectal cancer (23 papers), Colorectal Cancer Treatments and Studies (13 papers) and Epigenetics and DNA Methylation (10 papers). Diego Arango collaborates with scholars based in Spain, United States and Finland. Diego Arango's co-authors include John M. Mariadason, Leonard H. Augenlicht, Andrew J. Wilson, Simó Schwartz, Georgia Corner, Do-Sun Byun, Lauri A. Aaltonen, Courtney Nicholas, Lucas B. Murray and Maria Aranes and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Diego Arango

82 papers receiving 5.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diego Arango Spain 38 3.2k 2.0k 955 877 484 83 5.2k
Kazuya Shinmura Japan 37 3.1k 1.0× 1.2k 0.6× 874 0.9× 1.1k 1.3× 691 1.4× 142 4.6k
Franca Stivala Italy 28 3.5k 1.1× 1.6k 0.8× 653 0.7× 868 1.0× 514 1.1× 58 5.4k
Andrei L. Gartel United States 39 5.4k 1.7× 2.3k 1.1× 695 0.7× 1.2k 1.3× 402 0.8× 84 6.8k
Amardeep S. Dhillon Australia 25 3.6k 1.1× 1.1k 0.6× 683 0.7× 740 0.8× 325 0.7× 44 4.9k
Juliane M. Jürgensmeier United States 30 3.7k 1.2× 1.3k 0.6× 477 0.5× 738 0.8× 533 1.1× 69 5.4k
Judith S. Sebolt–Leopold United States 33 4.9k 1.5× 2.7k 1.4× 1.0k 1.1× 790 0.9× 591 1.2× 67 6.8k
Oliver Stoeltzing United States 43 3.0k 0.9× 1.6k 0.8× 312 0.3× 1.4k 1.6× 538 1.1× 73 4.6k
Camilla Evangelisti Italy 38 4.5k 1.4× 1.4k 0.7× 534 0.6× 860 1.0× 386 0.8× 90 6.4k
F. Michael Yakes United States 15 3.4k 1.1× 2.3k 1.1× 524 0.5× 679 0.8× 1.1k 2.3× 20 5.9k
Igor Vivanco United States 20 5.0k 1.6× 2.0k 1.0× 778 0.8× 1.3k 1.5× 1.3k 2.8× 28 7.0k

Countries citing papers authored by Diego Arango

Since Specialization
Citations

This map shows the geographic impact of Diego Arango's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Arango with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Arango more than expected).

Fields of papers citing papers by Diego Arango

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego Arango. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Arango. The network helps show where Diego Arango may publish in the future.

Co-authorship network of co-authors of Diego Arango

This figure shows the co-authorship network connecting the top 25 collaborators of Diego Arango. A scholar is included among the top collaborators of Diego Arango based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego Arango. Diego Arango is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cartón‐García, Fernando, Higinio Dopeso, Irati Macaya, et al.. (2022). Myosin Vb as a tumor suppressor gene in intestinal cancer. Oncogene. 41(49). 5279–5288. 2 indexed citations
2.
Bazzocco, Sarah, Higinio Dopeso, Águeda Martínez‐Barriocanal, et al.. (2021). Identification of ZBTB18 as a novel colorectal tumor suppressor gene through genome-wide promoter hypermethylation analysis. Clinical Epigenetics. 13(1). 88–88. 6 indexed citations
3.
Gallo-Oller, Gabriel, Guillem Pons, Miguel F. Segura, et al.. (2021). Dickkopf-1 Inhibition Reactivates Wnt/β-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In Vivo. International Journal of Molecular Sciences. 22(23). 12921–12921. 6 indexed citations
4.
Andrade, Fernanda, Diana Rafael, Sara Montero‐Herradón, et al.. (2021). Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo. Journal of Controlled Release. 331. 198–212. 47 indexed citations
5.
Martínez‐Barriocanal, Águeda, José Antonio Casado, Marı́a José Ramı́rez, et al.. (2020). Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia–Related Head and Neck Cancer. Clinical Cancer Research. 26(12). 3044–3057. 21 indexed citations
6.
Gener, Petra, Joaquin Seras‐Franzoso, Fernanda Andrade, et al.. (2018). Dynamism, Sensitivity, and Consequences of Mesenchymal and Stem-Like Phenotype of Cancer Cells. Stem Cells International. 2018. 1–12. 19 indexed citations
7.
Tögel, Lars, Anderly C. Chüeh, Aparna Jayachandran, et al.. (2016). Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells. Molecular Cancer Therapeutics. 15(6). 1217–1226. 74 indexed citations
8.
Bazzocco, Sarah, Higinio Dopeso, Fernando Cartón‐García, et al.. (2015). Highly Expressed Genes in Rapidly Proliferating Tumor Cells as New Targets for Colorectal Cancer Treatment. Clinical Cancer Research. 21(16). 3695–3704. 30 indexed citations
9.
Mouradov, Dmitri, Clare Sloggett, Robert N. Jorissen, et al.. (2014). Colorectal Cancer Cell Lines Are Representative Models of the Main Molecular Subtypes of Primary Cancer. Cancer Research. 74(12). 3238–3247. 287 indexed citations
10.
Dávalos, Verónica, Lucía Suárez-López, Julio Castaño, et al.. (2012). Human SMC2 Protein, a Core Subunit of Human Condensin Complex, Is a Novel Transcriptional Target of the WNT Signaling Pathway and a New Therapeutic Target. Journal of Biological Chemistry. 287(52). 43472–43481. 37 indexed citations
11.
Arango, Diego, Sheren Al-Obaidi, David S. Williams, et al.. (2012). Villin Expression Is Frequently Lost in Poorly Differentiated Colon Cancer. American Journal Of Pathology. 180(4). 1509–1521. 26 indexed citations
12.
Wilson, Andrew J., Anderly C. Chüeh, Lars Tögel, et al.. (2010). Apoptotic Sensitivity of Colon Cancer Cells to Histone Deacetylase Inhibitors Is Mediated by an Sp1/Sp3-Activated Transcriptional Program Involving Immediate-Early Gene Induction. Cancer Research. 70(2). 609–620. 96 indexed citations
13.
Dopeso, Higinio, Silvia Mateo‐Lozano, Élena Elez, et al.. (2010). Aprataxin Tumor Levels Predict Response of Colorectal Cancer Patients to Irinotecan-based Treatment. Clinical Cancer Research. 16(8). 2375–2382. 32 indexed citations
14.
Dopeso, Higinio, Silvia Mateo‐Lozano, Rocco Mazzolini, et al.. (2009). The Receptor Tyrosine Kinase EPHB4 Has Tumor Suppressor Activities in Intestinal Tumorigenesis. Cancer Research. 69(18). 7430–7438. 50 indexed citations
16.
Jorissen, Robert N., Peter Gibbs, Michael Christie, et al.. (2009). Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer. Clinical Cancer Research. 15(24). 7642–7651. 343 indexed citations
17.
Jhawer, Minaxi, Sanjay Goel, Andrew J. Wilson, et al.. (2008). PIK3CA Mutation/PTEN Expression Status Predicts Response of Colon Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Cetuximab. Cancer Research. 68(6). 1953–1961. 370 indexed citations
18.
Dávalos, Verónica, Higinio Dopeso, Julio Castaño, et al.. (2006). EPHB4 and Survival of Colorectal Cancer Patients. Cancer Research. 66(18). 8943–8948. 66 indexed citations
19.
Alazzouzi, Hafid, Verónica Dávalos, Antti Kokko, et al.. (2005). Mechanisms of Inactivation of the Receptor Tyrosine Kinase EPHB2 in Colorectal Tumors. Cancer Research. 65(22). 10170–10173. 75 indexed citations
20.
Alhopuro, Pia, Hafid Alazzouzi, Heli Sammalkorpi, et al.. (2005). SMAD4 Levels and Response to 5-Fluorouracil in Colorectal Cancer. Clinical Cancer Research. 11(17). 6311–6316. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026